Amyloidosis of the gastrointestinal tract: A 13-year, single-center, referral experience

Haematologica

Volumn 98, Issue 1, 2013, Pages 141-146

  Cowan, Andrew J ^a   Skinner, Martha ^a   Seldin, David C ^a,b   Berk, John L ^a   Lichtenstein, David R ^b   O'Hara, Carl J ^b   Doros, Gheorghe ^c   Sanchorawala, Vaishali ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; BORTEZOMIB; CYCLOPHOSPHAMIDE; DEXAMETHASONE; IMMUNOGLOBULIN LIGHT CHAIN; LENALIDOMIDE; LYSOZYME; MELPHALAN; PREALBUMIN; PREDNISONE; RITUXIMAB; THALIDOMIDE;

ABDOMINAL PAIN; ADULT; AGED; AMYLOIDOSIS; ARTICLE; CLINICAL TRIAL (TOPIC); DIARRHEA; DRUG MEGADOSE; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TRACT AMYLOIDOSIS; HEARTBURN; HUMAN; HUMAN TISSUE; IMMUNOGOLD ELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PLASMA CELL DYSCRASIA; RETROSPECTIVE STUDY; SATIETY; STEM CELL TRANSPLANTATION; WEIGHT REDUCTION;

ADULT; AGED; AMYLOIDOSIS; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84872053456     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2012.068155     Document Type: Article

References (24)

1. Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003; 349(6):583-96.
2. Sattianayagam PT, Hawkins PN, Gillmore JD. Systemic amyloidosis and the gastrointestinal tract. Nat Rev Gastroenterol Hepatol. 2009;6(10):608-17.
3. Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, et al. Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis. Amyloid. 2010;17(3-4):101-4.
4. Dember LM. Emerging treatment approaches for the systemic amyloidoses. Kidney Int. 2005;68(3):1377-90.
5. Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, Ikeda S, et al. A primer of amyloid nomenclature. Amyloid. 2007;14(3):179-83.
6. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med. 1997;337 (13):898-909.
7. Sattianayagam PT, Gibbs SD, Rowczenio D, Pinney JH, Wechalekar AD, Gilbertson JA, et al. Hereditary lysozyme amyloidosis-phenotypic heterogeneity and the role of solid organ transplantation. J Intern Med. 2012;272(1):36-44.
8. Charlot M, Seldin DC, O'Hara C, Skinner M, Sanchorawala V. Localized amyloidosis of the breast: a case series. Amyloid. 2011; 18(2):72-5.
9. Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol. 2005;79(4):319-28.
10. Hayman SR, Lacy MQ, Kyle RA, Gertz MA. Primary systemic amyloidosis: a cause of malabsorption syndrome. Am J Med. 2001;111(7):535-40.
11. Madsen LG, Gimsing P, Schiodt FV. Primary (AL) amyloidosis with gastrointestinal involvement. Scand J Gastroenterol. 2009; 44(6):708-11.
12. Suhr O, Danielsson A, Holmgren G, Steen L. Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Intern Med. 1994;235(5):479-85.
13. Suhr OB, Anan I, Ahlstrom KR, Rydh A. Gastric emptying before and after liver transplantation for familial amyloidotic polyneuropathy, Portuguese type (Val30Met). Amyloid. 2003;10(2):121-6.
14. Tada S, Iida M, Iwashita A, Matsui T, Fuchigami T, Yamamoto T, et al. Endoscopic and biopsy findings of the upper digestive tract in patients with amyloidosis. Gastrointest Endosc. 1990;36(1): 10-4.
15. Ebert EC, Nagar M. Gastrointestinal manifestations of amyloidosis. Am J Gastroenterol. 2008;103(3):776-87.
16. Duston MA, Skinner M, Anderson J, Cohen AS. Peripheral neuropathy as an early marker of AL amyloidosis. Arch Intern Med. 1989;149(2):358-60.
17. Biewend ML, Menke DM, Calamia KT. The spectrum of localized amyloidosis: a case series of 20 patients and review of the literature. Amyloid. 2006;13(3):135-42.
18. Hamidi Asl K, Liepnieks JJ, Nakamura M, Benson MD. Organ-specific (localized) synthesis of Ig light chain amyloid. J Immunol. 1999;162(9):5556-60.
19. Cibeira MT, Sanchorawala V, Seldin DC, Quillen K, Berk JL, Dember LM, et al. Outcome of AL amyloidosis after highdose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients. Blood. 2011;118(16):4346-52.
20. Seldin DC, Andrea N, Berenbaum I, Berk JL, Connors L, Dember LM, et al. Highdose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution. Amyloid. 2011;18 (Suppl 1):122-4.
21. Comenzo RL, Gertz MA. Autologous stem cell transplantation for primary systemic amyloidosis. Blood. 2002;99(12):4276-82.
22. Skinner M, Sanchorawala V, Seldin DC, Dember LM, Falk RH, Berk JL, et al. Highdose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med. 2004;140(2):85-93.
23. Matsutani H, Hoshii Y, Setoguchi M, Kawano H, Gondo T, Takahashi M, et al. Vascular amyloid of unknown origin and senile transthyretin amyloid in the lung and gastrointestinal tract of old age: histological and immunohistochemical studies. Pathol Int. 2001;51(5):326-32.
24. Saglam F, Celik A, Cavdar C, Sifil A, Atila K, Kaya GC, et al. A renal transplant recipient with delayed gastric emptying in amyloidosis due to familial Mediterranean fever improved with erythromycin: a case report. Transplant Proc. 2008;40(1):308-9.